Prospective, randomised, controlled study to examine the success of treating minor hepatocellular damage with endogenous electromagnetic fields

The study examined 28 patients with chronic hepatocellular damage whose condition had been known about for at least a year but had not been treated with drugs and whose laboratory values (GOT, GPT and gamma-GT) were slightly raised. 14 patients were assigned to the treatment group and 14 to the control group. Both groups had the same enzymatous values when treatment started.

The therapeutic effect was determined from the GOT, GPT and gamma-GT values. On completion of the study the values of the group treated with BICOM were within the limits of normal while the values of the control group were still within the pathological range. The following table shows the percentage decrease in the values:

Hepatic values	Decrease towards normal of excess values (BICOM treatment)	Decrease towards normal of excess values (control group)
GOT	42 %	4 %
GPT	50 %	5 %
Gamma-GT	38 %	7 %

In the test group the geometric mean values for the degree of improvement were 45% for GOT values (5% for control group), 55% for GPT activity (control group displayed a slight deterioration) and the degree of improvement was 45% for gamma-GT activity (slight deterioration in the control group).

It is clear from the experimental evidence presented that treating minor hepatocellular damage with BICOM therapy in the frequency range between 10 Hz and 150 kHz can bring about reconstitution of damaged hepatic cells.

Therefore the results of this study definitely prove the effectiveness of BICOM Bioresonance Therapy.

The study was conducted by R. Machowinski, randomisation and code list by the Naturopathy Outpatients Clinic of the Carstens Foundation of the University of Heidelberg under the direction of Prof. Dr. med. I. Gerhard.